CTCX vs. MODD, XAIR, LNSR, CODX, DXR, AKLI, RVP, DRIO, LUCD, and ICU
Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Modular Medical (MODD), Beyond Air (XAIR), LENSAR (LNSR), Co-Diagnostics (CODX), Daxor (DXR), Akili (AKLI), Retractable Technologies (RVP), DarioHealth (DRIO), Lucid Diagnostics (LUCD), and SeaStar Medical (ICU). These companies are all part of the "surgical & medical instruments" industry.
Modular Medical (NASDAQ:MODD) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, community ranking, analyst recommendations and institutional ownership.
Modular Medical has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500.
Modular Medical currently has a consensus target price of $4.25, indicating a potential upside of 140.11%. Given Carmell's higher possible upside, research analysts clearly believe Modular Medical is more favorable than Carmell.
Modular Medical received 2 more outperform votes than Carmell when rated by MarketBeat users.
27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Carmell had 2 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Carmell and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.46 beat Carmell's score of 0.00 indicating that Carmell is being referred to more favorably in the news media.
Modular Medical's return on equity of -171.27% beat Carmell's return on equity.
Summary
Modular Medical beats Carmell on 7 of the 11 factors compared between the two stocks.
Get Carmell News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
